Christopher Longhurst, MD, was selected as the next CEO of Seattle Children’s, the largest pediatric and adolescent academic medical center in the region.
Effective Jan. 5, Dr. Longhurst will succeed Jeff Sperring, MD, who announced in August his plans to retire after 10 years at the helm.
“Dr. Longhurst’s unique ability to merge clinical operations, research and digital strategy, while enhancing patient safety and quality, makes him the right leader to guide Seattle Children’s into the future,” Kurt Shintaffer, chair of the Seattle Children’s board of trustees, said in a news release. “His visionary leadership, deep clinical expertise, commitment to health equity and proven record of innovation will strengthen Seattle Children’s mission to serve children and families across the region and beyond.”
Dr. Longhurst will join Seattle Children’s from UC San Diego Health, where he is chief clinical and innovation officer.
Dr. Longhurst is also executive director of the Joan and Irwin Jacobs Center for Health Innovation at UC San Diego Health, and associate dean at the health system’s medical school.
Before joining UC San Diego Health, Dr. Longhurst was a pediatric hospitalist and chief medical information officer at Palo Alto, Calif.-based Stanford Children’s Health.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
